Elizabeth Varki Jobes

Senior Vice President, Chief Compliance Officer North America


Elizabeth Varki Jobes is Senior Vice President, Chief Compliance Officer North America.

In this role, she oversees the strategic direction of EMD Serono’s comprehensive compliance program and ensures all legal and regulatory requirements are met.

Prior to her current role, Elizabeth served as Global Chief Compliance Officer and Legal Counsel for Spark Therapeutics, Inc., where she was responsible for building a corporate compliance program supporting the launch of the first-approved gene therapy in the United States. Jobes also held Chief Compliance Officer positions with Auxilium Pharmaceuticals, Inc., and Adolor (Cubist) Corporation, as well as an executive position with Cephalon, Inc.

Elizabeth has more than 25 years of both in-house and law firm professional experience. She started her career as an attorney for the Philadelphia District Attorney’s Office.

Elizabeth holds a J.D. from Rutgers University School of Law and a B.A. from Pennsylvania State University.    


You have accessed https://www.emdserono.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement